Implementation Guide CH VACD
6.0.0 - trial-use
This page is part of the CH VACD (R4) (v6.0.0: STU 6) based on FHIR (HL7® FHIR® Standard) R4. This is the current published version. For a full list of available versions, see the Directory of published versions
Profile: CH VACD Medication For Immunization
identifier: urn:oid:2.999.1.2.3.4/359000dc-2cee-4a6e-ab05-577f558840e2
code: HAVRIX 1440 Inj Susp
status: Active
manufacturer: Organization GlaxoSmithKline AG
form: Suspension for injection
amount: 1 milliliter (Details: UCUM codemL = 'mL')/1 Syringe (unit of presentation) (Details: SNOMED CT code733020007 = 'Syringe')
| Item[x] |
| Immunologic substance (substance) |
| LotNumber |
| AHAVB946A |